[Controlled clinical study of the use of creatinol-O-phosphate in subjects with deficient myocardial circulation].
作者信息
Guglielmi G, Mammarella A
出版信息
Clin Ter. 1979 Nov 30;91(4):355-82.
PMID:396100
Abstract
摘要
相似文献
1
[Controlled clinical study of the use of creatinol-O-phosphate in subjects with deficient myocardial circulation].
Clin Ter. 1979 Nov 30;91(4):355-82.
2
Creatinol O-phosphate therapy in patients with inadequate coronary circulation. Double-blind clinical trial.
Arzneimittelforschung. 1979;29(9a):1483-5.
3
Activity of creatinol O-phosphate on persistent ventricular premature beats in ischemic heart disease. Double blind clinical trial.
Arzneimittelforschung. 1979;29(9a):1488-90.
4
[Clinical study on the effects of creatinol-O-phosphate in patients with heart diseases under digitalis treatment].[磷酸肌醇对接受洋地黄治疗的心脏病患者影响的临床研究]
Minerva Med. 1972 Nov 17;63(82):4470-81.
5
Clinical impressions of a new beta-adrenergic blocking drug, 39,089-Ba.新型β-肾上腺素能阻滞剂39,089-Ba的临床印象
N Z Med J. 1967 Oct;66(422):682-3.
6
Antiarrhythmic effectiveness of creatinol O-phosphate in man.
Arzneimittelforschung. 1979;29(9a):1485-7.
7
[Clinical results and statistical analysis of the use of creatinol-O-phosphate].[磷酸肌醇的临床应用结果及统计分析]
Med Monatsschr. 1977 Nov;31(11):526-9.
8
[Clinical experiments with a new myocardiotrophic agent].
Clin Ter. 1970 Sep 15;54(5):441-53.
9
[Interventricular septum extract in the treatment of some heart diseases].[室间隔提取物在某些心脏病治疗中的应用]
Minerva Med. 1969 Jun 20;60(49):2432-8.
10
[Double-blind clinical trial of a new coronary-active drug, MD 6753].
Minerva Cardioangiol. 1974 Oct;22(10):683-90.
引用本文的文献
1
Bioavailability, Efficacy, Safety, and Regulatory Status of Creatine and Related Compounds: A Critical Review.肌酸及其相关化合物的生物利用度、疗效、安全性和监管状况：批判性评价。
Nutrients. 2022 Feb 28;14(5):1035. doi: 10.3390/nu14051035.
2
Analysis of the efficacy, safety, and regulatory status of novel forms of creatine.新型肌酸形式的疗效、安全性和监管状况分析。
Amino Acids. 2011 May;40(5):1369-83. doi: 10.1007/s00726-011-0874-6. Epub 2011 Mar 22.
Zotero 插件